[1]Casaburi I, et al. Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment. Front Endocrinol (Lausanne). 2018 Sep 11;9:525.|[2]Dietschy JM, et al. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004 Aug;45(8):1375-97.|[3]Fukui K, et al. Effect of Cholesterol Reduction on Receptor Signaling in Neurons. J Biol Chem. 2015 Sep 14.|[4]Puskás LG, et al. Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett. 2004 Mar 26;562(1-3):99-104.|[5]Onody A, et al. Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res. 2003 Jun 1;58(3):663-70.|[6]Baumer Y, et al. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun. 2017 Oct 24;8(1):1129.|[7]Finking G, et al. Nikolaj Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis. 1997 Nov;135(1):1-7.|[8]Fan J, et al. Use of Rabbit Models to Study Atherosclerosis. Methods Mol Biol. 2022;2419:413-431.ACS Appl Mater Interfaces. 2024 Aug 5.|Adv Sci (Weinh). 2024 Aug 9:e2402329.|Adv Sci (Weinh). 2024 Jul 1:e2403640.|Antiviral Res. 2022 Dec 15;209:105497.|Biochem Biophys Res Commun. 2020 Feb 19;522(4):862-868.|Cell Death Discov. 2024 May 29;10(1):263.|Cell Metab. 2024 Oct 4:S1550-4131(24)00371-1.|Cell Mol Life Sci. 2024 Jul 6;81(1):289.|Cell Signal. 2024 Sep 16:111419.|EMBO Mol Med. 2024 Jul 19.|Free Radic Biol Med. 2024 Aug 27:S0891-5849(24)00623-3.|Int J Pharm. 2024 Aug 18:124608.|iScience. 2024 Apr 3.|J Nanobiotechnology. 2022 Oct 20;20(1):454.|J Pharm Sci. 2024 May 25:S0022-3549(24)00199-0.|Life Sci Alliance. 2022 Jan 4;5(3):e202101256.|Life Sci. 2023 Apr 18;121698.|Nanomedicine. 2024 Mar 16:102745.|Nat Chem Biol. 2022 Aug 18.|Nat Commun. 2024 Jan 2;15(1):162.|Nat Nanotechnol. 2021 Oct;16(10):1150-1160.|Nature. 2024 Dec 18.|Part Part Syst Charact. 2024 Jun 12.|Patent. US20200376102A1.|Patent. US20200376146A1.|Phytomedicine. 2024 Jan 20, 155299.|Polym Test. 2023 Dec 1, 108292.|Redox Biol. 2023 Jun.|Sci China Life Sci. 2021 May 27;1-21.|SSRN. 2024 Feb 5.|Theranostics. 2021 Jan 1;11(2):841-860.|Vet Microbiol. 2024 Jan, 288, 109948.|Viruses. 2022, 14(3), 514.|Adv Sci (Weinh). 2023 Sep;10(27):e2206878.|Immunity. 2024 May 14;57(5):1087-1104.e7.